Lexicon Pharmaceuticals Statistics
NASDAQ: LXRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.760.00 (0.00%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Lexicon Pharmaceuticals by the numbers
Lexicon Pharmaceuticals has a market capitalization of $783.1 million based on 444.96M shares outstanding. With trailing EPS of $-0.16, Lexicon Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.3% below its 50-day average and 5.2% below its 200-day average.
Average daily trading volume is 2.90M shares, or about $5.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LXRX valuation vs. peer median
| Metric | LXRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $783.12M | $776.69M | +1% |
| Avg. volume | 2.90M | 1.52M | +91% |
Peer median across 8 companies: HELP, GERN, IVA, IMMX, APMD, ANNX, OBX, AVBP.
Valuation
- Market cap
- $783.12M
- EPS (TTM)
- $-0.16
- Shares outstanding
- 444.96M
Price and trading
- Previous close
- 1.76
- Open
- 1.75
- Day range
- 1.70 – 1.78
- 52-week range
- 1.10 – 2.68
- 52-week change
- +23.08%
- Beta
- —
- Volume
- 3.32M
- Average volume
- 2.90M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 783.12M
- Forward Pe
- -9.23
- Eps
- -0.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.68
- Week52 Low
- 1.10
- Avg Volume
- 2.90M
- Shares Outstanding
- 444.96M
- Ma50
- 2.16
- Ma200
- 1.86
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -34.33%
- Pct From52w Low
- 60.00%